Press releases
- Dexcom Reports First Quarter 2024 Financial Results
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
- Dexcom Announces Upcoming Conference Presentation
- Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- Dexcom Launches Dexcom One+ Bringing Powerful, New Diabetes Management Technology to More People
More ▼
Key statistics
On Friday, Dexcom Inc (DC4X:GER) closed at 120.08, -8.88% below its 52-week high of 131.78, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 120.50 |
---|---|
High | 124.60 |
Low | 120.08 |
Bid | 118.94 |
Offer | 119.34 |
Previous close | 126.92 |
Average volume | 294.40 |
---|---|
Shares outstanding | 396.03m |
Free float | 394.61m |
P/E (TTM) | 107.65 |
Market cap | 54.66bn USD |
EPS (TTM) | 1.28 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 16:35 BST.
More ▼